World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
102
Citations
66767
World Ranking
7487
National Ranking
3914

Overview

George W. Sledge is affiliated with Stanford University in the United States. Their research extensively covers fields in medicine, particularly focusing on oncology, pulmonary and respiratory medicine, cancer research, radiology, nuclear medicine and imaging, and genetics.

The scientist's work spans multiple main topics including:

  • Cancer Genomics and Diagnostics
  • Advanced Breast Cancer Therapies
  • Cancer Immunotherapy and Biomarkers
  • Breast Cancer Treatment Studies
  • HER2/EGFR in Cancer Research
  • Colorectal Cancer Treatments and Studies
  • Lung Cancer Treatments and Mutations

George W. Sledge has contributed to numerous publications, with frequent appearances in the following venues:

  • Journal of Clinical Oncology (59 publications)
  • Cancer Research (29 publications)
  • Oncology Times (18 publications)
  • Clinical Cancer Research (13 publications)
  • Breast Cancer Research and Treatment (7 publications)

Their recent papers include:

  • Liquid biopsy enters the clinic - implementation issues and future challenges, 2021, Nature Reviews Clinical Oncology
  • 6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7), 2024, The Breast
  • A randomized phase III trial of systemic therapy plus early local therapy versus systemic therapy alone in women with de novo stage IV breast cancer: A trial of the ECOG-ACRIN Research Group (E2108), 2020, Journal of Clinical Oncology
  • Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial, 2020, JNCI Journal of the National Cancer Institute
  • Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx, 2020, Journal of Clinical Oncology

Frequent co-authors in their scientific work include:

  • Joanne Xiu
  • Matthew J. Oberley
  • David Spetzler
  • Andrew Elliott
  • Milan Radovich

Best Publications

  • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

    O. Abe;R. Abe;K. Enomoto;K. Kikuchi

  • Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

    Kathy S Albain;William E Barlow;Steven Shak;Gabriel N Hortobagyi

  • 3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)

    F. Cardoso;A. Costa;E. Senkus;M. Aapro

  • MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2- Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy.

    George W. Sledge;Masakazu Toi;Patrick Neven;Joohyuk Sohn

  • Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

    J. A. Sparano;R. J. Gray;D. F. Makower;K. I. Pritchard

  • Phase I Safety and Pharmacokinetic Study of Recombinant Human Anti-Vascular Endothelial Growth Factor in Patients With Advanced Cancer

    M. S. Gordon;K. Margolin;M. Talpaz;G. W. Sledge

  • Postmastectomy Radiotherapy: Clinical Practice Guidelines of the American Society of Clinical Oncology*

    Abram Recht;Stephen B. Edge;Lawrence J. Solin;David S. Robinson

  • Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer

    Joseph A. Sparano;Joseph A. Sparano;Molin Wang;Silvana Martino;Vicky Jones

  • Randomized Study of Lapatinib Alone or in Combination With Trastuzumab in Women With ErbB2-Positive, Trastuzumab-Refractory Metastatic Breast Cancer

    Kimberly L. Blackwell;Harold J. Burstein;Anna Maria Storniolo;Hope Rugo

  • Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth.

    Harikrishna Nakshatri;Poornima Bhat-Nakshatri;Daniel A. Martin;Robert J. Goulet

  • Trastuzumab Plus Adjuvant Chemotherapy for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Planned Joint Analysis of Overall Survival From NSABP B-31 and NCCTG N9831

    Edith A. Perez;Edward H. Romond;Vera J. Suman;Jong Hyeon Jeong

  • Integrated digital error suppression for improved detection of circulating tumor DNA

    Aaron M Newman;Alexander F Lovejoy;Daniel M Klass;David M Kurtz

  • Phase III Trial of Doxorubicin, Paclitaxel, and the Combination of Doxorubicin and Paclitaxel as Front-Line Chemotherapy for Metastatic Breast Cancer: An Intergroup Trial (E1193)

    George W. Sledge;Donna Neuberg;Patricia Bernardo;James N. Ingle

  • Association of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 Genetic Polymorphisms With Outcome in a Trial of Paclitaxel Compared With Paclitaxel Plus Bevacizumab in Advanced Breast Cancer: ECOG 2100

    Bryan P. Schneider;Molin Wang;Milan Radovich;George W. Sledge

  • The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor-Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy-MONARCH 2: A Randomized Clinical Trial

    George W. Sledge;Masakazu Toi;Patrick Neven;Joohyuk Sohn

  • Liquid biopsy enters the clinic - implementation issues and future challenges.

    Michail Ignatiadis;George W. Sledge;Stefanie S. Jeffrey

  • ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)

    F. Cardoso;A. Costa;L. Norton;E. Senkus

  • Cardiac Safety Analysis of Doxorubicin and Cyclophosphamide Followed by Paclitaxel With or Without Trastuzumab in the North Central Cancer Treatment Group N9831 Adjuvant Breast Cancer Trial

    Edith A. Perez;Vera J. Suman;Nancy E. Davidson;George W. Sledge

  • Overall Survival Benefit With Lapatinib in Combination With Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: Final Results From the EGF104900 Study

    Kimberly L. Blackwell;Harold J. Burstein;Anna Maria Storniolo;Hope S. Rugo

  • A Phase I/II Dose-Escalation Trial of Bevacizumab in Previously Treated Metastatic Breast Cancer

    Melody A Cobleigh;Virginia K Langmuir;George W Sledge;Kathy D Miller

Frequent Co-Authors

Kathy D. Miller
Kathy D. Miller Indiana University
Joseph A. Sparano
Joseph A. Sparano Albert Einstein College of Medicine
Sunil Badve
Sunil Badve Emory University
Edith A. Perez
Edith A. Perez Mayo Clinic
Daniel F. Hayes
Daniel F. Hayes University of Michigan–Ann Arbor
Masakazu Toi
Masakazu Toi Kyoto University
Nancy E. Davidson
Nancy E. Davidson University of Washington
Matthew P. Goetz
Matthew P. Goetz Mayo Clinic
Timothy J. Whelan
Timothy J. Whelan McMaster University
David Cella
David Cella Northwestern University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens up many alternative and complementary educational options in healthcare. If you’re considering flexible study options, online degrees can offer an efficient path into the field.

For aspiring nurses, absn programs that don't require teas make nursing accessible for those who prefer to bypass traditional standardized entrance exams. Similarly, registered nurses looking to advance their careers may consider asn to nurse practitioner programs, which offer a direct bridge to advanced practice without a lengthy return to undergraduate studies.

Management-minded students can step into leadership roles in hospitals and clinics through an online healthcare management degree, preparing them for administrative and executive career paths. Additionally, for those interested in diet, wellness, or public health, an online bachelor's degree in nutrition provides the foundation needed for roles in clinical, community, or corporate nutrition.

Whether your goal is direct patient care, healthcare leadership, or public health advocacy, these online programs offer diverse opportunities and flexible scheduling that fit a wide range of career goals.

Best Scientists Citing George W. Sledge

Trending Scientists

Recently Published Articles